Efficacy and safety of preoperative transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis

References

• Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the american association for the study of liver diseases. Hepatology. 2018;68(2):723–750.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA A Cancer J Clin. 2020;70(1):7–30.
   PubMed Web of Science ®Google Scholar
• Hur MH, Lee JH, Kim JY, et al. Comparison of overall survival between surgical resection and radiofrequency ablation for hepatitis B-related hepatocellular carcinoma. Cancers (Basel). 2021;13(23):6009.
   PubMed Web of Science ®Google Scholar
• Zhou WP, Lai EC, Li AJ, et al. A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma. Ann Surg. 2009;249(2):195–202.
   PubMed Web of Science ®Google Scholar
• Agrawal S, Belghiti J. Oncologic resection for malignant tumors of the liver. Ann Surg. 2011;253(4):656–665.
   PubMed Web of Science ®Google Scholar
• Arii S, Teramoto K, Kawamura T, et al. Characteristics of recurrent hepatocellular carcinoma in Japan and our surgical experience. J Hepatobiliary Pancreat Surg. 2001;8(5):397–403.
   PubMedGoogle Scholar
• Bin Q, Bo Z, Zhaohong W, et al. Comparative study of TACE combined with surgery and surgery alone in the treatment of primary hepatocellular carcinoma. Chinese Foreign Med Res. 2014;12(10):61–62.
   Google Scholar
• El-Gendi AM, El-Shafei M, Bedewy E. Combined liver resection and transarterial chemoembolization versus liver resection alone for the management of solitary large exophytic hepatocellular carcinoma with extrahepatic arterial supply: is two always better than one? Egypt J Surg. 2018;37(1):78–88.
   Web of Science ®Google Scholar
• Tang QH, Zhou JP, Fu SY, et al. Effect of preoperative transcatheter arterial chemoembolization for treatment of resectable large hepatocellular carcinoma: a clinical randomized controlled trial. Acad J Sec Mil Med Univ. 2010;29(12):1379–1384.
   Google Scholar
• Li C, Wang MD, Lu L, et al. Preoperative transcatheter arterial chemoembolization for surgical resection of huge hepatocellular carcinoma (≥ 10 cm): a multicenter propensity matching analysis. Hepatol Int. 2019;13(6):736–747.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Tuo F, Li R, et al. Transarterial chemoembolization combined with hepatectomy for the treatment of intermediate-stage hepatocellular carcinoma. Front Oncol. 2020;10:578763.
   PubMed Web of Science ®Google Scholar
• Zhang YF, Guo RP, Zou RH, et al. Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study. Eur Radiol. 2016;26(7):2078–2088.
   PubMed Web of Science ®Google Scholar
• Shi HY, Wang SN, Wang SC, et al. Preoperative transarterial chemoembolization and resection for hepatocellular carcinoma: a nationwide Taiwan database analysis of long-term outcome predictors. J Surg Oncol. 2014;109(5):487–493.
   PubMed Web of Science ®Google Scholar
• Cheng X, Sun P, Hu QG, et al. Transarterial (chemo)embolization for curative resection of hepatocellular carcinoma: a systematic review and meta-analyses. J Cancer Res Clin Oncol. 2014;140(7):1159–1170.
   PubMed Web of Science ®Google Scholar
• Si T, Chen Y, Ma D, et al. Preoperative transarterial chemoembolization for resectable hepatocellular carcinoma in Asia area: a meta-analysis of random controlled trials. Scand J Gastroenterol. 2016;51(12):1512–1519.
   PubMed Web of Science ®Google Scholar
• Wu CC, Ho YZ, Ho WL, et al. Preoperative transcatheter arterial chemoembolization for resectable large hepatocellular carcinoma: a reappraisal. Br J Surg. 1995;82(1):122–126.
   PubMed Web of Science ®Google Scholar
• Gao ZH, Bai DS, Jiang GQ, et al. Review of preoperative transarterial chemoembolization for resectable hepatocellular carcinoma. World J Hepatol. 2015;7(1):40–43.
   PubMedGoogle Scholar
• Jianyong L, Jinjing Z, Wentao W, et al. Preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: a single center analysis. Ann Hepatol. 2014;13(4):394–402.
   PubMed Web of Science ®Google Scholar
• Guo C, Zou X, Hong Z, et al. Preoperative transarterial chemoembolization for Barcelona Clinic liver cancer stage a/B hepatocellular carcinoma beyond the Milan criteria: a propensity score matching analysis. HPB (Oxford). 2021;23(9):1427–1438.
   PubMed Web of Science ®Google Scholar
• Jianyong L, Jinjing Z, Lunan Y, et al. Preoperative adjuvant transarterial chemoembolization cannot improve the long term outcome of radical therapies for hepatocellular carcinoma. Sci Rep. 2017;7:41624.
   PubMed Web of Science ®Google Scholar
• Xinhui L, Yanxia Q, Rongchen L. The effect of TACE before tumor resection on the prognosis of patients with stage B liver cancer in Barcelona. Shandong Medical Journal. 2014;54(15):11–13.
   Google Scholar
• Yang Y, Lin K, Liu L, et al. Impact of preoperative TACE on incidences of microvascular invasion and long-term post-hepatectomy survival in hepatocellular carcinoma patients: a propensity score matching analysis. Cancer Med. 2021;10(6):2100–2111.
   PubMed Web of Science ®Google Scholar
• Chao W, Liqun W, Bin Z. Effect of preoperative TACE on prognosis of patients with hepatocellular carcinoma after hepatectomy. Chinese J Curr Adv Gen Surg. 2010;13(03):220–222.
   Google Scholar
• Gerunda GE, Neri D, Merenda R, et al. Role of transarterial chemoembolization before liver resection for hepatocarcinoma. Liver Transplant. 2000;6(5):619–626.
   PubMed Web of Science ®Google Scholar
• Ha TY, Hwang S, Lee YJ, et al. Absence of benefit of transcatheter arterial chemoembolization (TACE) in patients with resectable solitary hepatocellular carcinoma. World J Surg. 2016;40(5):1200–1210.
   PubMed Web of Science ®Google Scholar
• Harada T, Matsuo K, Inoue T, et al. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg. 1996;224(1):4–9.
   PubMed Web of Science ®Google Scholar
• Kaibori M, Tanigawa N, Matsui Y, et al. Influence of transcatheter arterial chemoembolization on the prognosis after hepatectomy for hepatocellular carcinoma in patients with severe liver dysfunction. Anticancer Res. 2006;26(5B):3685–3692.
   PubMed Web of Science ®Google Scholar
• Kim IS, Lim YS, Lee HC, et al. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome. Aliment Pharmacol Ther. 2007;27(4):338–345.
   PubMed Web of Science ®Google Scholar
• Kishi Y, Saiura A, Yamamoto J, et al. Preoperative transarterial chemoembolization for hepatocellular carcinoma. Hepato-Gastroenterology. 2012;59(119):2295–2299.
   PubMedGoogle Scholar
• Lee KT, Lu YW, Wang SN, et al. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes. J Surg Oncol. 2009;99(6):343–350.
   PubMed Web of Science ®Google Scholar
• Liu YJ, Zhang XM, Zhang JX, et al. Transarterial chemoembolization as an adjuvant therapy in patients with hepatocellular carcinoma treated with hepatectomy. Chinese J Radiol. 2010;44(8):847–851.
   Google Scholar
• Murakami M, Nagano H, Kobayashi S, et al. Effects of pre-operative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: implication of circulating cancer cells by detection of alpha-fetoprotein mRNA. Exp Ther Med. 2010;1(3):485–491.
   PubMed Web of Science ®Google Scholar
• Park GC, Lee SG, Yoon YI, et al. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma. Hepatobil Pancreat Dis Int. 2020;19(3):244–251.
   PubMed Web of Science ®Google Scholar
• Sasaki A, Iwashita Y, Shibata K, et al. Preoperative transcatheter arterial chemoembolization reduces long-term survival rate after hepatic resection for resectable hepatocellular carcinoma. Eur J Surg Oncol. 2006;32(7):773–779.
   PubMed Web of Science ®Google Scholar
• Wang TH, Ren ZG, Ye QH, et al. Effect of preoperative adjuvant transcatheter hepatic arterial chemoembolization on prognosis of resectable huge hepatocellular carcinoma. Chinese J Cancer Prevent Treat. 2010;17(15):1210–1213.
   Google Scholar
• Wu XS, Li ML, Wu WG, et al. The role of preoperative TACE on hepatocellular carcinoma located in caudate lobe. Zhonghua Wai Ke Za Zhi. 2013;51(9):780–783.
   PubMedGoogle Scholar
• Choi GH, Kim DH, Kang CM, et al. Is preoperative transarterial chemoembolization needed for a resectable hepatocellular carcinoma? World J Surg. 2007;31(12):2370–2377.
   PubMed Web of Science ®Google Scholar
• Majno PE, Adam R, Bismuth H, et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg. 1997;226(6):688–701.
   PubMed Web of Science ®Google Scholar
• Sugof H, Futagawa S, Beppu T, et al. Role of preoperative transcatheter arterial chemoembolization for resectable hepatocellular carcinoma: relation between postoperative course and the pattern of tumor recurrence. World J Surg. 2003;27(12):1295–1299.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Liu Q, He J, et al. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma. Cancer. 2000;89(12):2606–2612.
   PubMed Web of Science ®Google Scholar
• Hongfeng L, Xuejun Y. Effect of preoperative TACE on curative effect and prognosis of 62 patients with liver cancer resection. China Pract Med. 2013;8(08):126–127.
   Google Scholar
• Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The liver cancer study group of Japan. Hepatology. 2000;32(6):1224–1229.
   PubMed Web of Science ®Google Scholar
• Kow AW, Kwon CH, Song S, et al. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution. Ann Surg Oncol. 2012;19(7):2246–2255.
   PubMed Web of Science ®Google Scholar
• Toyoda H, Kumada T, Kiriyama S, et al. Comparison of the usefulness of three staging systems for hepatocellular carcinoma (CLIP, BCLC, and JIS) in Japan. Am J Gastroenterol. 2005;100(8):1764–1771.
   PubMed Web of Science ®Google Scholar
• Chan AWH, Zhong J, Berhane S, et al. Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection. J Hepatol. 2018;69(6):1284–1293.
   PubMed Web of Science ®Google Scholar
• Roayaie S, Jibara G, Taouli B, et al. Resection of hepatocellular carcinoma with macroscopic vascular invasion. Ann Surg Oncol. 2013;20(12):3754–3760.
   PubMed Web of Science ®Google Scholar
• Jung SM, Kim JM, Choi GS, et al. Characteristics of early recurrence after curative liver resection for solitary hepatocellular carcinoma. J Gastrointest Surg. 2019;23(2):304–311.
   PubMed Web of Science ®Google Scholar
• Poon RT, Fan ST, Ng IO, et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89(3):500–507.
   PubMed Web of Science ®Google Scholar
• Adachi E, Matsumata T, Nishizaki T, et al. Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis. Cancer. 1993;72(12):3593–3598.
   PubMed Web of Science ®Google Scholar
• Clavien PA, Selzner N, Morse M, et al. Downstaging of hepatocellular carcinoma and liver metastases from colorectal cancer by selective intra-arterial chemotherapy. Surgery. 2002;131(4):433–442.
   PubMed Web of Science ®Google Scholar
• Lee HS, Kim KM, Yoon JH, et al. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol. 2002;20(22):4459–4465.
   PubMed Web of Science ®Google Scholar
• Lei Z, Li J, Wu D, et al. Nomogram for preoperative estimation of microvascular invasion risk in hepatitis B virus-related hepatocellular carcinoma within the Milan criteria. JAMA Surg. 2016;151(4):356–363.
   PubMed Web of Science ®Google Scholar
• Xu X, Zhang HL, Liu QP, et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J Hepatol. 2019;70(6):1133–1144.
   PubMed Web of Science ®Google Scholar